Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial.
Heart Protection Study Collaborative Group, Bulbulia R, Bowman L, Wallendszus K, Parish S, Armitage J, Peto R, Collins R.
Lancet. 2011 Dec 10;378(9808):2013-20. Epub 2011 Nov 22.
Related citations
Cardiovascular health advice for children in the USA.
[No authors listed]
Lancet. 2011 Nov 26;378(9806):1826. No abstract available.
Glycaemia and heart failure in diabetes types 1 and 2.
Opie LH.
Lancet. 2011 Jul 9;378(9786):103-4. Epub 2011 Jun 24. No abstract available.
No mental health without physical health.
Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J.
Lancet. 2011 Feb 19;377(9766):611. No abstract available.
National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants.
Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol).
Lancet. 2011 Feb 12;377(9765):578-86. Epub 2011 Feb 3.
Stemming the global tsunami of cardiovascular disease.
Anand SS, Yusuf S.
Lancet. 2011 Feb 12;377(9765):529-32. Epub 2011 Feb 4. No abstract available.
Health inequalities in the UK.
Meldrum H, Buckman L.
Lancet. 2010 Dec 11;376(9757):1983. No abstract available.
Is intensive LDL-cholesterol lowering beneficial and safe?
Cheung BM, Lam KS.
Lancet. 2010 Nov 13;376(9753):1622-4. Epub 2010 Nov 8. No abstract available.
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage J, Bowman L, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Peto R, Collins R.
Lancet. 2010 Nov 13;376(9753):1658-69. Epub 2010 Nov 8. Erratum in: Lancet. 2011 Jan 8;377(9760):126.
Triglyceride-mediated pathways and coronary heart disease.
Zeng D, Zheng QS, Ou DB.
Lancet. 2010 Sep 18;376(9745):957; author reply 957-8. No abstract available.
Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.
Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, Gregg E, Holman RR, Kirkman MS, Stern M, Tuomilehto J, Wareham NJ.
Lancet. 2010 Apr 17;375(9723):1365-74. Epub 2010 Mar 29. Erratum in: Lancet. 2010 Apr 17;375(9723):1346.
An unusual cause of joint swelling.
Sharma A, Dogra S, Mahajan R, Wanchu A, Singh S.
Lancet. 2010 Mar 27;375(9720):1109. No abstract available.
Antisense technology to lower LDL cholesterol.
Neely RD, Bassendine MF.
Lancet. 2010 Mar 20;375(9719):959-61. No abstract available.
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.
Raal FJ, Santos RD, Blom DJ, Marais AD, Charng MJ, Cromwell WC, Lachmann RH, Gaudet D, Tan JL, Chasan-Taber S, Tribble DL, Flaim JD, Crooke ST.
Lancet. 2010 Mar 20;375(9719):998-1006.
White blood.
Lommerse K, Mwagomba B, van den Akker T.
Lancet. 2010 Mar 6;375(9717):801; author reply 801. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on